Background: This study compared the surgical and urinary functional outcomes in
Although robotic surgery has advanced, experience with totally intracorporeal orthotopic ileal neobladder reconstruction (ICNB) remains limited. Most surgeons have performed a hybrid approach, with RARC and extracorporeal reconstruction of urinary diversion, because ICNB remains technically challenging. [6] [7] [8] To date, the adoption of ICNB has been confined to high-volume academic institutions worldwide. However, several techniques for ICNB have been reported with promising functional outcomes. [9] [10] [11] The ideal continent reservoir should have adequate capacity and low pressure in the storage phase and high compliance to help with continence, and it should allow voluntary emptying without residual urine. 12 We previously reported the surgical procedure and functional outcomes of our original cross-folded U-configuration extracorporeal ileal neobladder reconstruction (ECNB). 13, 14 We applied the open surgery technique to ICNB formation. Herein, we report our initial experience with 22 MIBC patients who underwent RARC with U-shaped ICNB, which replicates the open technique. In addition, we compared urinary functional outcomes of ICNB with those of ECNB.
| MATERIALS AND METHODS

| Study population
In this retrospective study, we reviewed the clinical and pathological records of 445 consecutive MIBC patients who underwent RC and pelvic lymphadenectomy (PLND) between May 1994 and December 2017 at Hirosaki University. Our study focused on MIBC patients who underwent neoadjuvant chemotherapy (NAC) followed by RC and ileal neobladder reconstruction.
The study protocol and informed consent documents were reviewed and approved by the Hirosaki University institutional review board (authorization number: 2013-271).
| Treatment schedule
All treatments were performed at our institution. All patients received two cycles of gemcitabine and cisplatin or carboplatin (CBDCA) and/or New York Heart Association Class III heart failure. 18 
| Surgical procedure
Robot-assisted radical cystectomy with ICNB was performed by two experienced robotic surgeons. Our surgical technique for RARC has been described in detail previously. 19 In all, seven trocars were used.
The patients were placed in the Trendelenburg position (25°). The peritoneum was incised, and the anterior cavity of the bladder was sufficiently exposed. The endopelvic fascia was incised, and the dorsal vein complex was ligated. The posterior layer of Denonvilliers' fascia was then incised in the midline between the rectum or vagina and the bladder. The ureters were divided close to the bladder. The lateral vascular bundles were incised close to the bladder. The plane of urethral dissection was directed under the dorsal vein complex and through the anterior prostatic fibromuscular stroma. Pelvic lymphadenectomy, including the hypogastric, external iliac, and obturator nodes, was routinely performed in both procedures. Our surgical technique for minimum incision endoscopic RC (MIE-RC) has also been previously described in detail. 20 Our U-shaped ICNB technique replicates the ECNB technique at our institution. 13, 14 The first step is to identify the most mobile ileum that reaches the urethra without tension. A 40-cm bowel segment is chosen for the neobladder, using a fenestrated forceps and a Cadiere grasper. A monopolar scissors is used to create a small opening in the centre of the bowel segment. An 18-F urethral catheter is inserted through the urethra to irrigate the future neobladder and to minimize spillage of ileal contents ( Figure 1A ).
The second step is to divide approximately 5 cm of the peritoneum with the bowel mesentery. Two mesenteric windows are created, using a monopolar scissors. After ensuring that the bowel segment has maintained good vascularity, a 60-mm Endo-GIA stapler is passed through the 15-mm assistant port to divide the bowel lumen both proximally and distally, using the Covidien iDrive Ultra Powered Stapling System. Anastomosis is performed with a 60-mm Endo-GIA stapler for the side-to-side part and 60-mm loads for the horizontal part, using the iDrive.
The third step is to fix the ileal segment at the pelvic floor The fifth step is to make the uretero-ileal anastomosis. Two small enterotomies are created in the U-flap, and the ureters are introduced into the future neobladder. A 4-0 braided polyglactin suture (7-cm long) is used to make an anastomosis with interrupted sutures. After transection of the ureter using a monopolar scissors, an anchoring suture is placed using a 4-0 braided polyglactin suture. A 6-F single-J ureteric stent is placed over a guidewire that is inserted through the urethra. An 18-F urethral catheter with 10-mL balloon is subsequently inserted through the urethra. After ureteral anastomosis, the U-flap is cross-folded to make a pouch ( Figure 1E ). The remaining anterior neobladder wall is closed using 15-cm 3-0 V-Loc sutures ( Figure 1F ).
Finally, the peritoneal window is closed to place the neobladder in the extraperitoneal position (the pelvis).
| Patient evaluation
The IV: complications causing residual and lasting disability requiring major rehabilitation or organ resection; V: complications causing death). 22 
| Training for voiding
Patients with the neobladder were advised to void every 2 hours for the first 3 months. Subsequently, the voiding records were checked, and the patients were allowed to void according to their preference.
| Follow-up
Each patient was evaluated every 3 months using ultrasonography to check for hydronephrosis and to monitor renal and liver function.
Computed tomography was performed every 6 months for early detection of recurrence. Cystourethroscopic examination was performed at 3-month intervals during the first and second years and at 6-month intervals thereafter.
| Urinary function
The patients were asked about their voiding behaviour, presence or absence of incontinence, and pad requirements. Continence status was evaluated by the number of pads the patient required during 24 hours. Continence was defined as good if a patient used 0-1 pad daily. Urodynamic studies, including cystometry, urethral pressure profilometry, and uroflowmetry, were also performed at 3, 6, 9, and 12 months after surgery.
| Statistical analysis
The endpoints in this study were surgical outcomes, including operative time, EBL, perioperative complications, and urinary function. Data 
| Surgical outcomes
Surgical outcomes and perioperative complications are shown in Table 2 . Robot-assisted radical cystectomy with ICNB was successfully completed in all patients without open conversion. The operative time in the ICNB group was significantly longer than in the ECNB group. The median estimated blood loss was less, and the transfusion rate was significantly lower in the ICNB group than in the ECNB group (P < 0.001).
| Pathological outcomes
All patients were evaluated for pathological outcomes. 
| Complications
No intraoperative complications were associated with this procedure. 3.5 | Aspects of surgery influencing the perioperative outcomes after RARC Table 5 lists the effects of specific surgical aspects on perioperative outcomes. Median operation time in the last eight cases was significantly lower than that in the first seven cases (P < 0.001). Median EBL and rates of perioperative complications were not significantly different among the three groups.
| Oncological outcomes
At the end of the follow-up period, two patients (9.1%) in the ICNB group and 11 (8.4%) in the ECNB group died of bladder cancer. Nine patients (5.9%), including two in the ICNBC group and seven in the ECNB group, developed clinical recurrence. Figure 2 shows the chronological changes in median capacity and residual urine in the cross-folded U-configuration ileal neobladder.
| Urinary function
The median neobladder capacity at 6 and 12 months after surgery was 276 and 285 mL in the ICNB group and 274 and 309 mL in the ECNB group, respectively. There were no statistically significant differences between the groups. The median residual volume at 6 and 12 months after surgery was 40 and 29 mL in the ICNB group and 0 and 0 mL in the ECNB group. At 9 months after surgery, the residual urine in the ICNB group was significantly greater than in the ECNB group (P = 0.002). Figure 3 shows the chronological changes in maximum neobladder pressure (Pdet) and maximum urethral closure pressure (MUCP) in the cross-folded U-configuration ileal neobladder.
The median Pdet at 6 and 12 months after surgery was 19.0 and were no significant differences between the groups. The Qmax at 3 months after surgery was 12.7 mL/s in the ICNB group and 14.8 mL/s in the ECNB group, and was maintained throughout the follow-up period (data not shown). There were no significant differences between the groups. Figure 4 shows the continence status. Daytime and night-time continence gradually improved in both groups. There were no significant differences in continence rate between the groups during the follow-up period. Two patients (9.1%) in the RARC group and three (2.3%) in the ECNB group required transient clean intermittent catheterization (CIC) because of greater than 150-mL residual urine.
| DISCUSSION
In previous studies, we reported on the open surgical technique and functional outcomes with use of a U-shaped ileal neobladder.
13,14
Our procedure is simpler, and the operative time is relatively short. 13, 14 In this study, we reported on our robot-assisted ICNB Abbreviations: ECIN, extracorporeal ileal neobladder; ICNB, intracorporeal ileal neobladder; IQR, interquartile range; MIE-RC, minimum incision endoscopic radical cystectomy; RC, radical cystectomy; PLND, pelvic lymph node dissection; RARC, robot-assisted radial cystectomy. Chronologic changes in neobladder capacity and residual urine volume. The neobladder capacity gradually increased in both groups. There were no statistically significant differences between the groups. The residual urine volume remained relatively low throughout the follow-up period in both groups. At 9 months after surgery, the residual urine in the ICNB group was significantly greater than that in the ECNB group (P = 0.002) The daytime and night-time continence status gradually improved in both groups. There were no statistically significant differences between the groups throughout the follow-up period reconstruction, with the most common surgery-related complication being infection (24.4%). 27 In addition, 23 patients (2.3%) died within 90 days after surgery. 27 In an analysis based on the IRCC database, the major complication rate was 20% in RARC patients with intracorporeal urinary diversion, whereas 32% was reported for extracorporeal urinary diversion. 9 In this study, grade 3 Clavien-Dindo complications occurred in the ICNB group, 22 and none of the patients died within 90 days after surgery. However, the complication rates were similar to those reported in large open or RARC series. 9, 27 It is important to provide patients who undergo ICNB with the best possible urinary continence to maintain their quality of life.
Tyritzis et al reported a daytime continence rate of 88% in men and 67% in women at 12 months and night-time continence rates of 76%. 28 Simone et al reported 1-year daytime and night-time continence rates of 73.3% and 55.5%, respectively. 29 In the ICNB group, daytime and night-time continence rates at 12 months were 93.4%
and 93.4%, respectively. In addition, 10% of the patients required CIC. These results were similar in the ECNB group. Studer and Turner
proposed that an ideal neobladder should have a large capacity for storage and low pressure and high compliance for continence and should permit voluntary emptying without residual urine. 12 Our surgical technique with ICNB may provide acceptable urinary function. In addition, voiding education may play an important role in achieving a reduced amount of residual urine.
The current study has several limitations. First, this was a retrospective study, with an inherent potential for bias. Second, a relatively small number of patients were enrolled in this study, and the follow-up period was relatively short. A longer period of careful observation for oncological and functional consequences is necessary.
| CONCLUSIONS
Our initial experience with cross-folded U-configuration ICNB was favourable, with acceptable surgical outcomes and voiding function after surgery.
